Clinical Trial Update: Twice Yearly Treatment for the Control of LF [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for twice-yearly treatment targeting lymphatic filariasis and helminth infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helminth Infection
• Lymphatic Filariasis

Snippet

Sponsor: Noguchi Memorial Institute for Medical Research | Conditions: Lymphatic Filariasis, Helminth Infection | Phase 4 | Status: COMPLETED